Integrated Master in Pharmaceutical Sciences

Pharmacology II

ECTS

7

Learning outcomes

Students shall aquire general and specific knowledge and understanding of the mode of action behind the different pharmacological classes as well the drugs representing each class. Students will uderstand the structure/activity relationships in each pharmacological class, the mechanisms and the pharmacological action and the therapeutic use of drugs, their Pharmacokinetic attributes relevant for the clinical use, the therapeutic indications and the potential for inducing adverse drug reactions and/or interactions (drug/drug, drug/food,). In general the international denomination is used. Students will develop the ability and aquire the comptetence to recognise the pharmacological activity and therapeutic potential of drugs acting in the different organ systems and develop the capacity to understand/learn innovative modes of action (MoA) as well as anticipating the potential for therapeutic use of the innovative molecules/MoA, and their limitations in different patient populations.

Syllabus

Drugs representing different pharmacotherapeutic classes, MoA, pharmacokinetics , therapeutic use, adverse reactions and interactions
Cardiovascular system:
antihypertensive/cardiotonics/Antiarrhythmics/drugs for coronary heart disease
endocrine system and metabolic disorders: Antidiabetics: insulins/ hypoglycemic and anti-hiperglycemic drugs/Antithyroid drugs and thyroid hormones/
Central Nervous System:
Antipsychotics/Antidepressants/Anxiolytics/Hypnotics and sedatives; Anticonvulsants; antiparkinsonic/cognitive dysfunctions–Alzheimer's dementia.
Chemotherapeutics:antibiotics/antifungals/antivirals/anti-protozoals/ antihelminthics.  Antiseptics and sterilising agents.
Anticancer drugs-Radiotherapics/chemotherapics/immunotherapics.Tirosin kinase inhibitors, targeted formulations. New strategies in cancer therapy: monoclonal antibodies/byspecific antibodies/fusion proteinas/ Drug-antibody combinations/advanced therapies.

Share